Vincent Loic A sold $37K of KRRO
Vincent Loic A (Chief Scientific Officer) sold 3,418 shares of Korro Bio, Inc. (KRRO) at $10.83 on 2026-06-16.
How this was made
The 30-second read
Why it matters
The newest fact is the specific open-market sale size, price, and post-transaction holdings by the CSO.
Market read
Traders may monitor insider activity for sentiment, but this filing alone does not provide new operational or financial guidance.
What to watch
The article does not state whether the sale was part of a 10b5-1 plan (it says no), but it also provides no context on compensation, tax liabilities, or prior sale patterns.
Background
The article is a SEC Form 4 insider transaction report for Korro Bio, Inc.
Ticker impact
Korro Bio CSO Vincent Loic A filed a Form 4 open-market sale of 3,418 shares at $10.83 on 2026-06-16.
Likely limited, with any impact confined to short-term sentiment rather than fundamentals.
The filing is a routine insider transaction with no 10b5-1 plan and no accompanying operational or guidance change disclosed in the text.
Market effects
Minimal, as the disclosure does not indicate sector-wide regulatory, clinical, or financing developments.
None indicated.
None indicated.
Counterpoint
Insider sales can be planned for diversification or tax needs, so the signal may be weaker than it appears.
Key entities
- issuerKorro Bio, Inc.
Subject of the Form 4 insider transaction disclosure.
- insiderVincent Loic A
Chief Scientific Officer who sold 3,418 shares.
